PAI
Palo Alto Investors’s Syndax Pharmaceuticals SNDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.16M | Hold |
444,367
| – | – | 0.89% | 20 |
|
|
2025
Q1 | $5.46M | Buy |
444,367
+39,174
| +10% | +$481K | 1.04% | 20 |
|
|
2024
Q4 | $5.36M | Hold |
405,193
| – | – | 0.83% | 20 |
|
|
2024
Q3 | $7.8M | Hold |
405,193
| – | – | 1.01% | 20 |
|
|
2024
Q2 | $8.32M | Hold |
405,193
| – | – | 0.96% | 19 |
|
|
2024
Q1 | $9.64M | Sell |
405,193
-67,407
| -14% | -$1.6M | 1.09% | 20 |
|
|
2023
Q4 | $10.2M | Hold |
472,600
| – | – | 0.92% | 19 |
|
|
2023
Q3 | $6.86M | Sell |
472,600
-140,000
| -23% | -$2.03M | 0.65% | 19 |
|
|
2023
Q2 | $12.8M | Hold |
612,600
| – | – | 1.04% | 15 |
|
|
2023
Q1 | $12.9M | Hold |
612,600
| – | – | 1.07% | 15 |
|
|
2022
Q4 | $15.6M | Hold |
612,600
| – | – | 1.33% | 14 |
|
|
2022
Q3 | $14.7M | Hold |
612,600
| – | – | 1.16% | 15 |
|
|
2022
Q2 | $11.8M | Hold |
612,600
| – | – | 1.03% | 17 |
|
|
2022
Q1 | $10.6M | Buy |
612,600
+13,700
| +2% | +$238K | 0.82% | 20 |
|
|
2021
Q4 | $13.1M | Buy |
598,900
+154,000
| +35% | +$3.37M | 0.84% | 21 |
|
|
2021
Q3 | $8.5M | Buy |
444,900
+43,800
| +11% | +$837K | 0.51% | 25 |
|
|
2021
Q2 | $6.89M | Buy |
401,100
+136,900
| +52% | +$2.35M | 0.38% | 25 |
|
|
2021
Q1 | $5.91M | Hold |
264,200
| – | – | 0.34% | 26 |
|
|
2020
Q4 | $5.88M | Buy |
264,200
+65,800
| +33% | +$1.46M | 0.31% | 24 |
|
|
2020
Q3 | $2.93M | Buy |
198,400
+70,700
| +55% | +$1.04M | 0.16% | 27 |
|
|
2020
Q2 | $1.89M | Buy |
127,700
+61,600
| +93% | +$913K | 0.11% | 29 |
|
|
2020
Q1 | $725K | Buy |
+66,100
| New | +$725K | 0.06% | 29 |
|